In HCC patients with no HBV infection, high SPC25 level caused a slightly higher OS disadvantage (HR:2.94, 95%CI:1.84-4.69, P < 0.001, Figure 2F). This evidence concerns the gene SPC25 and hepatocellular carcinoma.